RARRES1 antibody

Catalog No. ABIN7238444

Product Details anti-RARRES1 Antibody

Target: RARRES1 (Retinoic Acid Receptor Responder (Tazarotene Induced) 1 (RARRES1))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This RARRES1 antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (IHC), ELISA

Characteristics: Polyclonal Antibody

Purification: Affinity purification

Immunogen: Synthetic peptide of human RARRES1

Isotype: IgG

Application Details

Application Notes: WB 1:500-1:2000, IHC 1:100-1:300

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 0.7 mg/mL

Buffer: PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C. Avoid freeze / thaw cycles.

Target Details for RARRES1

Target: RARRES1 (Retinoic Acid Receptor Responder (Tazarotene Induced) 1 (RARRES1))

Alternative Name: RARRES1 (RARRES1 Products)

Synonyms: AI662122 antibody, 5430417P09Rik antibody, tig1 antibody, MGC68628 antibody, RARRES1 antibody, OCX32 antibody, LXNL antibody, TIG1 antibody, retinoic acid receptor responder (tazarotene induced) 1 antibody, retinoic acid receptor responder 1 antibody, retinoic acid receptor responder (tazarotene induced) 1 L homeolog antibody, Rarres1 antibody, rarres1.L antibody, RARRES1 antibody

Background: This gene was identified as a retinoid acid (RA) receptor-responsive gene. It encodes a type 1 membrane protein. The expression of this gene is upregulated by tazarotene as well as by retinoic acid receptors. The expression of this gene is found to be downregulated in prostate cancer, which is caused by the methylation of its promoter and CpG island. Alternatively spliced transcript variant encoding distinct isoforms have been observed.

Molecular Weight: 26 kDa

NCBI Accession: NP_002879

UniProt: P49788